Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas

References

• Amiot L, Onno M, Lamy T, Dauriac C, Le Prise PY, Fauchet R, Drenou B. Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course. Br J Haematol 1998; 100:655-63; PMID:9531330; http://dx.doi.org/10.1046/j.1365-2141.1998.00631.x
   PubMed Web of Science ®Google Scholar
• Challa-Malladi M, Lieu YK, Califano O, Holmes AB, Bhagat G, Murty VV, Dominguez-Sola D, Pasqualucci L, Dalla-Favera R. Combined genetic inactivation of beta2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell 2011; 20:728-40; PMID:22137796; http://dx.doi.org/10.1016/j.ccr.2011.11.006
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Dalla-Favera R. SnapShot: diffuse large B cell lymphoma. Cancer Cell 2014; 25:132-e1; PMID:24434215; http://dx.doi.org/10.1016/j.ccr.2013.12.012
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, Ouillette P, Trifonov V, Rossi D, Tabb∫ F et al. Genetics of follicular lymphoma transformation. Cell Rep 2014; 6:130-40; PMID:24388756; http://dx.doi.org/10.1016/j.celrep.2013.12.027
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Dalla-Favera R. The genetic landscape of diffuse large B-cell lymphoma. Semin Hematol 2015; 52:67-76; PMID:25805586; http://dx.doi.org/10.1053/j.seminhematol.2015.01.005
   PubMed Web of Science ®Google Scholar
• Green MR, Kihira S, Liu CL, Nair RV, Salari R, Gentles AJ, Irish J, Stehr H, Vicente-Dueñas C, Romero-Camarero I et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. Proc Natl Acad Sci U S A 2015; 112:E1116-25; PMID:25713363; http://dx.doi.org/10.1073/pnas.1501199112
   PubMed Web of Science ®Google Scholar
• Jiang Y, Melnick A. The epigenetic basis of diffuse large B-cell lymphoma. Semin Hematol 2015; 52:86-96; PMID:25805588; http://dx.doi.org/10.1053/j.seminhematol.2015.01.003
   PubMed Web of Science ®Google Scholar
• Laurent C, Charmpi K, Gravelle P, Tosolini M, Franchet C, Ysebaert L, Brousset P, Bidaut A, Ycart B, Fournié JJ. Several immune escape patterns in non-Hodgkin's lymphomas. OncoImmunology 2015; 4:e1026530; PMID:26405585; http://dx.doi.org/10.1080/2162402X.2015.1026530
   PubMed Web of Science ®Google Scholar
• Armand P. Checkpoint blockade in lymphoma. Hematology Am Soc Hematol Educ Program 2015; 2015:69-73; PMID:26637703; http://dx.doi.org/0.1182/asheducation-2015.1.69
   PubMedGoogle Scholar
• Armand P. Immune checkpoint blockade in hematologic malignancies. Blood 2015; 125:3393-400; PMID:25833961; http://dx.doi.org/10.1182/blood-2015-02-567453
   PubMed Web of Science ®Google Scholar
• Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M, Schuster SJ, Millenson MM, Cattry D, Freeman GJ et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med 2015; 372:311-9; PMID:25482239; http://dx.doi.org/10.1056/NEJMoa1411087
   PubMed Web of Science ®Google Scholar
• Berger R, Rotem-Yehudar R, Slama G, Landes S, Kneller A, Leiba M, Koren-Michowitz M, Shimoni A, Nagler A. Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin Cancer Res 2008; 14:3044-51; PMID:18483370; http://dx.doi.org/10.1158/1078-0432.CCR-07-4079
   PubMed Web of Science ®Google Scholar
• Westin JR, Chu F, Zhang M, Fayad LE, Kwak LW, Fowler N, Romaguera J, Hagemeister F, Fanale M, Samaniego F et al. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial. Lancet Oncol 2014; 15:69-77; PMID:24332512; http://dx.doi.org/10.1016/S1470-2045(13)70551-5
   PubMed Web of Science ®Google Scholar
• Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 2015; 21:938-45; PMID:26193342; http://dx.doi.org/10.1038/nm.3909
   PubMed Web of Science ®Google Scholar
• Hebestreit K, Grottrup S, Emden D, Veerkamp J, Ruckert C, Klein HU, Müller-Tidow C, Dugas M. Leukemia gene atlas–a public platform for integrative exploration of genome-wide molecular data. PLoS One 2012; 7:e39148; PMID:22720055; http://dx.doi.org/10.1371/journal.pone.0039148
   PubMed Web of Science ®Google Scholar
• Lee HK, Hsu AK, Sajdak J, Qin J, Pavlidis P. Coexpression analysis of human genes across many microarray data sets. Genome Res 2004; 14:1085-94; PMID:15173114; http://dx.doi.org/10.1101/gr.1910904
   PubMed Web of Science ®Google Scholar
• Mizuno H, Nakanishi Y, Ishii N, Sarai A, Kitada K. A signature-based method for indexing cell cycle phase distribution from microarray profiles. BMC Genomics 2009; 10:137; PMID:19331659; http://dx.doi.org/10.1186/1471-2164-10-137
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 2015; 12:453-7; PMID:25822800; http://dx.doi.org/10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545-50; PMID:16199517; http://dx.doi.org/10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Ycart B, Pont F, Fournie JJ. Curbing false discovery rates in interpretation of genome-wide expression profiles. J Biomed Inform 2014; 47:58-61; PMID:24060601; http://dx.doi.org/10.1016/j.jbi.2013.09.004
   PubMed Web of Science ®Google Scholar
• Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009; 462:108-12; PMID:19847166; http://dx.doi.org/10.1038/nature08460
   PubMed Web of Science ®Google Scholar
• Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17:98-110; PMID:20129251; http://dx.doi.org/10.1016/j.ccr.2009.12.020
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW, Levine DA et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 2013; 4:2612; PMID:24113773; http://dx.doi.org/10.1038/ncomms3612
   PubMed Web of Science ®Google Scholar
• Gundem G, Lopez-Bigas N. Sample-level enrichment analysis unravels shared stress phenotypes among multiple cancer types. Genome Med 2012; 4:28; PMID:22458606; http://dx.doi.org/10.1186/gm327
   PubMed Web of Science ®Google Scholar
• Ferreira PG, Jares P, Rico D, Gomez-Lopez G, Martinez-Trillos A, Villamor N, Ecker S, González-Pérez A, Knowles DG, Monlong J et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res 2014; 24:212-26; PMID:24265505; http://dx.doi.org/10.1101/gr.152132.112
   PubMed Web of Science ®Google Scholar
• Isensee J, Witt H, Pregla R, Hetzer R, Regitz-Zagrosek V, Noppinger PR. Sexually dimorphic gene expression in the heart of mice and men. J Mol Med (Berl) 2008; 86:61-74; PMID:17646949; http://dx.doi.org/10.1007/s00109-007-0240-z
   PubMed Web of Science ®Google Scholar
• Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403:503-11; PMID:10676951; http://dx.doi.org/10.1038/35000501
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003; 198:851-62; PMID:12975453; http://dx.doi.org/10.1084/jem.20031074
   PubMed Web of Science ®Google Scholar
• Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A 2003; 100:9991-6; PMID:12900505; http://dx.doi.org/10.1073/pnas.1732008100
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans HC, Beverstock GC, Mollevanger P, Wessels HW, Hoogendoorn E, Willemze R et al. Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood 1994; 84:3134-41; PMID:7524766
   PubMed Web of Science ®Google Scholar
• Ferry JA. Burkitt's lymphoma: clinicopathologic features and differential diagnosis. Oncologist 2006; 11:375-83; PMID:16614233; http://dx.doi.org/10.1634/theoncologist.11-4-375
   PubMed Web of Science ®Google Scholar
• Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 2008; 359:2313-23; PMID:19038878; http://dx.doi.org/10.1056/NEJMoa0802885
   PubMed Web of Science ®Google Scholar
• Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 2012; 490:116-20; PMID:22885699; http://dx.doi.org/10.1038/nature11378
   PubMed Web of Science ®Google Scholar
• Meignan M. Quantitative FDG-PET: a new biomarker in PMBCL. Blood 2015; 126:924-6; PMID:26294712; http://dx.doi.org/10.1182/blood-2015-07-653386
   PubMed Web of Science ®Google Scholar
• Wu X, Pertovaara H, Korkola P, Vornanen M, Eskola H, Kellokumpu-Lehtinen PL. Glucose metabolism correlated with cellular proliferation in diffuse large B-cell lymphoma. Leuk Lymphoma 2012; 53:400-5; PMID:21913807; http://dx.doi.org/10.3109/10428194.2011.622420
   PubMed Web of Science ®Google Scholar
• Xie M, Wu K, Liu Y, Jiang Q, Xie Y. Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants. Med Oncol 2015; 32:446; PMID:25511321; http://dx.doi.org/10.1007/s12032-014-0446-1
   PubMed Web of Science ®Google Scholar
• Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351:2159-69; PMID:15548776; http://dx.doi.org/10.1056/NEJMoa041869
   PubMed Web of Science ®Google Scholar
• Guillaume N, Marolleau JP. Is immune escape via human leukocyte antigen expression clinically relevant in chronic lymphocytic leukemia? Focus on the controversies. Leuk Res 2013; 37:473-7; PMID:23347904; http://dx.doi.org/10.1016/j.leukres.2012.12.021
   PubMed Web of Science ®Google Scholar
• Ysebaert L, Fournie JJ. Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia. Leuk Lymphoma 2011; 52:1404-6; PMID:21699388; http://dx.doi.org/10.3109/10428194.2011.568078
   PubMed Web of Science ®Google Scholar
• Germain C, Guillaudeux T, Galsgaard ED, Hervouet C, Tekaya N, Gallouet AS, Fassy J, Bihl F, Poupon G, Lazzari A et al. Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions. Oncoimmunology 2015; 4:e1026503; PMID:26405582; http://dx.doi.org/10.1080/2162402X.2015.1026503
   PubMed Web of Science ®Google Scholar
• God JM, Zhao D, Cameron CA, Amria S, Bethard JR, Haque A. Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition. Immunology 2014; 142:492-505; PMID:24628049; http://dx.doi.org/10.1111/imm.12281
   PubMed Web of Science ®Google Scholar
• Neelapu SS, Kwak LW, Kobrin CB, Reynolds CW, Janik JE, Dunleavy K, White T, Harvey L, Pennington R, Stetler-Stevenson M et al. Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma. Nat Med 2005; 11:986-91; PMID:16116429; http://dx.doi.org/10.1038/nm1290
   PubMed Web of Science ®Google Scholar
• Wang L, Qian J, Lu Y, Li H, Bao H, He D, Liu Z, Zheng Y, He J, Li Y et al. Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells. Haematologica 2013; 98:1458-66; PMID:23508008; http://dx.doi.org/10.3324/haematol.2012.071340
   PubMed Web of Science ®Google Scholar
• Xerri L, Chetaille B, Serriari N, Attias C, Guillaume Y, Arnoulet C, Olive D. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Hum Pathol 2008; 39:1050-8; PMID:18479731; http://dx.doi.org/10.1016/j.humpath.2007.11.012
   PubMed Web of Science ®Google Scholar
• Dasanu CA, Bockorny B, Grabska J, Codreanu I. Prevalence and Pattern of Autoimmune Conditions in Patients with Marginal Zone Lymphoma: A Single Institution Experience. Conn Med 2015; 79:197-200; PMID:26259295
   PubMedGoogle Scholar
• Mittal D, Gubin MM, Schreiber RD, Smyth MJ. New insights into cancer immunoediting and its three component phases–elimination, equilibrium and escape. Curr Opin Immunol 2014; 27:16-25; PMID:24531241; http://dx.doi.org/10.1016/j.coi.2014.01.004
   PubMed Web of Science ®Google Scholar
• Verhaak RG, Tamayo P, Yang JY, Hubbard D, Zhang H, Creighton CJ, Fereday S, Lawrence M, Carter SL, Mermel CH et al. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J Clin Invest 2013; 123:517-25; PMID:23257362; http://dx.doi.org/10.1172/JCI65833
   PubMed Web of Science ®Google Scholar
• Ycart B, Charmpi K, Rousseaux S, Fournie JJ. Large scale statistical analysis of GEO datasets. Gene Technol 2014; 3:1-9; http://dx.doi.org/10.4172/2329-6682.1000113
   Google Scholar
• Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004; 22:329-60; PMID:15032581; http://dx.doi.org/10.1146/annurev.immunol.22.012703.104803
   PubMed Web of Science ®Google Scholar
• Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30:207-10; PMID:11752295; http://dx.doi.org/10.1093/nar/30.1.207
   PubMed Web of Science ®Google Scholar
• Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004; 32:D258-61; PMID:14681407; http://dx.doi.org/10.1093/nar/gkh066
   PubMed Web of Science ®Google Scholar
• Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics 2011; 27:1739-40; PMID:21546393; http://dx.doi.org/10.1093/bioinformatics/btr260
   PubMed Web of Science ®Google Scholar
• Tsodikov A, Szabo A, Jones D. Adjustments and measures of differential expression for microarray data. Bioinformatics 2002; 18:251-60; PMID:11847073; http://dx.doi.org/10.1093/bioinformatics/18.2.251
   PubMed Web of Science ®Google Scholar
• Warnat P, Eils R, Brors B. Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes. Bmc Bio Informatics 2005; 6:265; PMID:16271137; http://dx.doi.org/10.1186/1471-2105-6-265
   PubMed Web of Science ®Google Scholar
• Charmpi K, Ycart B. Weighted Kolmogorov Smirnov testing: an alternative for Gene Set Enrichment Analysis. Statistical Applications Genetics Mol Biol 2015; 14:279-93; PMID:26030794; http://dx.doi.org/10.1515/sagmb-2014-0077
   PubMed Web of Science ®Google Scholar
• Cui X, Churchill GA. Statistical tests for differential expression in cDNA microarray experiments. Genome Biol 2003; 4:210; PMID:12702200; http://dx.doi.org/10.1186/gb-2003-4-4-210
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Wang C, Zhou Y, Speed TP. Gene set enrichment analysis made simple. Stat Methods Med Res 2009; 18:565-75; PMID:20048385; http://dx.doi.org/10.1177/0962280209351908
   PubMed Web of Science ®Google Scholar
• Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstråle M, Laurila E et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34:267-73; PMID:12808457; http://dx.doi.org/10.1038/ng1180
   PubMed Web of Science ®Google Scholar